SINGAPORE (Reuters) - Indian pharmaceutical company Strides Shasun Ltd has launched a share sale to raise funds up to 15 billion rupees ($225.7 million), IFR reported on Friday, citing a source close to the transaction.
Strides is selling shares at 1,278 rupees apiece in the transaction, which comprises a base deal for 10 billion rupees with an upsize option of 5 billion rupees, IFR, a Thomson Reuters publication, said.
Axis and Jefferies are the bookrunners for the deal, it said.
($1 = 66.4505 Indian rupees)
(Reporting by S. Anuradha; Editing by Gopakumar Warrier)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app